Abstract
On the 20th anniversary of the Alzheimer’s Disease Neuroimaging Initiative (ADNI), this paper provides a comprehensive overview of the role of arterial spin labeling (ASL) magnetic resonance imaging (MRI) in understanding perfusion changes in the aging brain and the relationship with Alzheimer’s disease (AD) pathophysiology and its comorbid conditions. We summarize previously used acquisition protocols, available data, and the motivation for adopting a multi-post-labeling delay (PLD) acquisition scheme in the latest ADNI MRI protocol (ADNI 4). We also detail the process of setting up this scheme on different scanners, emphasizing the potential of ASL imaging in future AD research.
Highlights
The Alzheimer’s Disease Neuroimaging Initiative (ADNI) adopted multimodal arterial spin labeling magnetic resonance imaging (ASL MRI) to meet evolving biomarker requirements.
The ADNI provides one of the largest multisite, multi-vendor ASL data collections.
The ADNI 4 incorporates multi-post-labeling delay ASL techniques to jointly quantify cerebral blood flow and arterial transit time.
ADNI 4 ASL MRI protocol is apt for detecting early Alzheimer’s disease with cerebrovascular pathology.
If you do not see content above, kindly GO TO SOURCE.
Not all publishers encode content in a way that enables republishing at Neuro.vip.
This post is Copyright: Pamela Thropp,
Eliana Phillips,
Youngkyoo Jung,
David L. Thomas,
Duygu Tosun,
for the Alzheimer’s Disease Neuroimaging Initiative | October 21, 2024